Life Sciences & Biotechnology
Targeting telomerase transcriptionally and posttranscriptionally using small molecules and anti-telomerase peptides: Potential double blow to aggressive drug resistant cancers
Targeting telomerase transcriptionally and posttranscriptionally using small molecules and anti-telomerase peptides: Potential double blow to aggressive drug resistant cancers
A combinatorial study and evaluation of role of therapeutic agents/inhibitors on JAK/STAT pathway
Anti-complement factor H (FH) associated hemolytic uremic syndrome (HUS) in children: Immunological and genetic basis, and functional characterization of autoantibodies
Anti-complement factor H (FH) associated hemolytic uremic syndrome (HUS) in children: Immunological and genetic basis, and functional characterization of autoantibodies
Role of negative co-stimulatory molecule V-set domaincontaining T-cell activation inhibitor-1 (VTCN1) in vitiligo pathogenesis
Design, synthesis and biological evaluation of HDAC3 selective inhibitors as long term memory enhancers
Immunophenotypic profile of tumour infiltrating cells of the immune system & expression of PDL1 in triple negative/Her-2 neu positive breast cancer patients and their correlation with response to neoadjuvant chemotherapy
Design of bromodomain inhibitors for its anticancer activity
Pharamacogenetic determinants of 6-mercaptopurine toxicity and relapse in children with acute lymphoblastic leukemia
Pages
